Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

SB 484Session 2025-2026

Moving marijuana from schedule I to schedule III of the uniform controlled substances act.

As Introduced

Underlined text would be added to current law. Struck-through text would be removed.

Skip to main content Kansas Legislature kslegislature.gov menu Home House account_balanceAbout the House groupsRepresentatives campaignEvents chairSeating Chart auto_storiesJournals & Calendars manage_accountsChief Clerk of the House gavelRules Senate account_balanceAbout the Senate groupsSenators campaignEvents assignment_indAppointments chairSeating Chart auto_storiesJournals & Calendars manage_accountsSecretary of the Senate gavelRules Committees groupsCommittees eventHearing Schedule handshakeConference Committee Schedule Measures & Laws gavelAll Measures account_balanceHouse Measures account_balanceSenate Measures account_balanceVotes topicSubject Index summarizeReports menu_bookStatutes schoolHow a Bill Becomes Law menu_bookLegislative Procedure Manual Today campaignLive Floor Activity videocamHouse Video videocamSenate Video live_tvStatehouse Live & Archive smart_displayYouTube Channel Resources Archive Search description Go to bill or resolution arrow_forward A− A+ search Search bills, resolutions, and statutes help

Keywords
Enter any words to search bills, statutes, and documents.
water quality funding

Bill or Resolution Number
Type a number and press Enter to go directly to the detail page.
HB 2590 SCR 1611

Statute Number
68-102 72-3715

Exact Phrase
Wrap your query in quotes.
“rules of evidence”

Document Type
Prefix with a type to narrow results.
testimony: HB 2513 minutes: budget

    Searching…

    No results found.

    search Search bills, resolutions, and statutes Home House About the House Representatives Events Seating Chart Journals & Calendars Chief Clerk of the House Rules Senate About the Senate Senators Events Appointments Seating Chart Journals & Calendars Secretary of the Senate Rules Committees All Committees Hearing Schedule Conference Committee Schedule Measures & Laws All Measures House Measures Senate Measures Votes Subject Index Reports Statutes How a Bill Becomes Law Legislative Procedure Manual Resources Today Live Floor Activity House Video Senate Video Statehouse Live & Archive YouTube Channel Archive Search
    1. SB 484›
    2. SB 484 — As Introduced

    Kansas Legislature

    SB 484 — As Introduced

    picture_as_pdf Download PDF Session of 2026SENATE BILL No. 484By Senator Holscher2-41AN ACT concerning the uniform controlled substances act; moving 2marijuana and tetrahydrocannabinols from schedule I to schedule III of 3the act; amending K.S.A. 21-5706 and 65-4109 and K.S.A. 2025 Supp. 465-4105 and repealing the existing sections.56Be it enacted by the Legislature of the State of Kansas:7Section 1. K.S.A. 21-5706 is hereby amended to read as follows: 21-85706. (a) It shall be unlawful for any person to possess any opiates, opium 9or narcotic drugs, or any stimulant designated in K.S.A. 65-4107(d)(1), (d)10(3) or (f)(1), and amendments thereto, or a controlled substance analog 11thereof.12(b) It shall be unlawful for any person to possess any of the following 13controlled substances or controlled substance analogs thereof:14(1) Any depressant designated in K.S.A. 65-4105(e), 65-4107(e), 65-154109(b) or (c) or 65-4111(b), and amendments thereto;16(2) any stimulant designated in K.S.A. 65-4105(f), 65-4107(d)(2), (d)17(4), (d)(5) or (f)(2) or 65-4109(e), and amendments thereto;18(3) any hallucinogenic drug designated in K.S.A. 65-4105(d), 65-194107(g) or 65-4109(g), and amendments thereto;20(4) any substance designated in K.S.A. 65-4105(g) and 65-4111(c), 21(d), (e), (f) or (g), and amendments thereto;22(5) any anabolic steroids as defined in K.S.A. 65-4109(f), and 23amendments thereto;24(6) any substance designated in K.S.A. 65-4113, and amendments 25thereto; or26(7) any substance designated in K.S.A. 65-4105(h), and amendments 27thereto.28(c) (1) Violation of subsection (a) is a drug severity level 5 felony.29(2) Except as provided in subsection (c)(3):30(A) Violation of subsection (b) is a class A nonperson misdemeanor, 31except as provided in subparagraph (B); and32(B) violation of subsection (b)(1) through (b)(5) or (b)(7) is a drug 33severity level 5 felony if that person has a prior conviction under such 34subsection, under K.S.A. 65-4162, prior to its repeal, under a substantially 35similar offense from another jurisdiction, or under any city ordinance or 36county resolution for a substantially similar offense if the substance 1involved was 3, 4-methylenedioxymethamphetamine (MDMA), marijuana 2as designated in K.S.A. 65-4105(d) 65-4109(h), and amendments thereto, 3or any substance designated in K.S.A. 65-4105(h), and amendments 4thereto, or an analog thereof.5(3) If the substance involved is marijuana, as designated in K.S.A. 665-4105(d) 65-4109(h), and amendments thereto, or 7tetrahydrocannabinols, as designated in K.S.A. 65-4105(h) 65-4109(i), and 8amendments thereto, violation of subsection (b) is a:9(A) Class B nonperson misdemeanor, except as provided in 10subparagraphs (B) and (C);11(B) class A nonperson misdemeanor if that person has a prior 12conviction under such subsection, under K.S.A. 65-4162, prior to its 13repeal, under a substantially similar offense from another jurisdiction, or 14under any city ordinance or county resolution for a substantially similar 15offense; and16(C) drug severity level 5 felony if that person has two or more prior 17convictions under such subsection, under K.S.A. 65-4162, prior to its 18repeal, under a substantially similar offense from another jurisdiction, or 19under any city ordinance or county resolution for a substantially similar 20offense.21(d) It shall be an affirmative defense to prosecution under this section 22arising out of a person's possession of any cannabidiol treatment 23preparation if the person:24(1) Has a debilitating medical condition, as defined in K.S.A. 2025 25Supp. 65-6235, and amendments thereto, or is the parent or guardian of a 26minor child who has such debilitating medical condition;27(2) is possessing a cannabidiol treatment preparation, as defined in 28K.S.A. 2025 Supp. 65-6235, and amendments thereto, that is being used to 29treat such debilitating medical condition; and30(3) has possession of a letter, at all times while the person has 31possession of the cannabidiol treatment preparation, that:32(A) Shall be shown to a law enforcement officer on such officer's 33request;34(B) is dated within the preceding 15 months and signed by the 35physician licensed to practice medicine and surgery in Kansas who 36diagnosed the debilitating medical condition;37(C) is on such physician's letterhead; and38(D) identifies the person or the person's minor child as such 39physician's patient and identifies the patient's debilitating medical 40condition.41(e) It shall not be a defense to charges arising under this section that 42the defendant was acting in an agency relationship on behalf of any other 43party in a transaction involving a controlled substance or controlled 1substance analog.2Sec. 2. K.S.A. 2025 Supp. 65-4105 is hereby amended to read as 3follows: 65-4105. (a) The controlled substances listed in this section are 4included in schedule I and the number set forth opposite each drug or 5substance is the DEA controlled substances code that has been assigned to 6it.7(b) Any of the following opiates, including their isomers, esters, 8ethers, salts, and salts of isomers, esters and ethers, unless specifically 9excepted, whenever the existence of these isomers, esters, ethers and salts 10is possible within the specific chemical designation:11(1) Acetyl fentanyl12(N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide)............................982113(2) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-14piperidinyl]-N-phenylacetamide)...........................................................981515(3) Acetylmethadol........................................................................960116(4) Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-17phenylacrylamide; acryloylfentanyl)......................................................981118(5) AH-7921 (3,4-dichloro-N-[(1-19dimethylamino)cyclohexylmethyl]benzamide)......................................955120(6) Allylprodine.............................................................................960221(7) Alphacetylmethadol.................................................................960322(except levo-alphacetylmethadol also known as levo-alpha-23acetylmethadol, levomethadyl acetate or LAAM)24(8) Alphameprodine.......................................................................960425(9) Alphamethadol.........................................................................960526(10) Alpha′-methyl butyryl fentanyl (2-methyl-N-(1-27phenethylpiperidin-4-yl)-N-phenylbutanamide)....................................986428(11) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-29piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) 30piperidine)..............................................................................................981431(12) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-32piperidinyl]-N-phenylpropanamide)......................................................983233(13) Benzethidine.............................................................................960634(14) Betacetylmethadol....................................................................960735(15) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-36piperidinyl]-N-phenylpropanamide)......................................................983037(16) Beta-hydroxy-3-methylfentanyl (other name: N-[1-(2-hydroxy-2-38phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide) 983139(17) Beta-hydroxythiofentanyl (N-[1-[2-hydroxy-2-(thiophen-2-40yl)ethyl]piperidin-4-yl]-N-phenylpropionamide)..................................983641(18) Betameprodine.........................................................................960842(19) Betamethadol...........................................................................960943(20) Beta-methyl fentanyl (N-phenyl-N-(1-(2-phenylpropyl)piperidin-14-yl)propionamide; also known as β-methyl fentanyl)..........................98562(21) Beta'-phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N, 3-3diphenylpropanamide; also known as β'-phenyl fentanyl; 3-4phenylpropanoyl fentanyl).....................................................................98425(22) Betaprodine..............................................................................96116(23) Brorphine (1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-1,3-7dihydro-2H-benzo[d]imidazol-2-one)....................................................90988(24) Butyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-9phenylbutyramide).................................................................................982210(25) Clonitazene..............................................................................961211(26) Crotonyl fentanyl ((E)-N-(1-phenethylpiperidin-4-yl)-N-12phenylbut-2-enamide)............................................................................984413(27) Cyclopentyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-14phenylcyclopentanecarboxamide)..........................................................984715(28) Cyclopropyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-16phenylcyclopropanecarboxamide).........................................................984517(29) Dextromoramide......................................................................961318(30) Diampromide...........................................................................961519(31) Diethylthiambutene..................................................................961620(32) Difenoxin.................................................................................916821(33) Dimenoxadol............................................................................961722(34) Dimepheptanol.........................................................................961823(35) 2′,5′-Dimethoxyfentanyl (N-(1-(2,5-24dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide)..............986125(36) Dimethylthiambutene...............................................................961926(37) Dioxaphetyl butyrate................................................................962127(38) Dipipanone...............................................................................962228(39) Ethylmethylthiambutene..........................................................962329(40) Etonitazene...............................................................................962430(41) Etoxeridine...............................................................................962531(42) Fentanyl carbamate (ethyl (1-phenethylpiperidin-4-yl)32(phenyl)carbamate).................................................................................985133(43) 2′-Fluoro ortho-fluorofentanyl (N-(1-(2-34fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)propionamide; also 35known as 2′-fluoro 2-fluorofentanyl).....................................................985536(44) Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-372-carboxamide).......................................................................................983438(45) 3-Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-39phenylfuran-3-40carboxamide)..........................................................................................986041(46) Furethidine...............................................................................962642(47) Hydroxypethidine.....................................................................962743(48) Isobutyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-1phenylisobutyramide).............................................................................98272(49) Isotonitazene (N,N-diethyl-2-(2-(4 isopropoxybenzyl)-5-nitro-31H-benzimidazol-1-yl)ethan-1-amine; N,N-diethyl-2-[[4-(1-4methylethoxy)phenyl]methyl]-5-nitro-1 H-benzimidazole-1-5ethanamine)............................................................................................96146(50) Isovaleryl fentanyl (3-methyl- N -(1-phenethylpiperidin-4-yl)-7N-phenylbutanamide).............................................................................98628(51) Ketobemidone..........................................................................96289(52) Levomoramide.........................................................................962910(53) Levophenacylmorphan.............................................................963111(54) Meta -Fluorofentanyl (N -(3-fluorophenyl)- N -(1-12phenethylpiperidin-4-yl)propionamide).................................................985713(55) Meta -Fluoroisobutyryl fentanyl ( N -(3-fluorophenyl)- N -(1-14phenethylpiperidin-4-yl)isobutyramide)................................................985815(56) Methoxyacetyl fentanyl (2-methoxy-N-(1-phenethylpiperidin-4-16yl)-N-phenylacetamide).........................................................................982517(57) 4′-Methyl acetyl fentanyl (N-(1-(4-methylphenethyl)piperidin-4-18yl)-N-phenylacetamide).........................................................................981919(58) 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-20phenylpropanamide)...............................................................................981321(59) 3-Methylthiofentanyl (N-[(3-methyl-1-(2-thienyl)ethyl-4-22piperidinyl]-N-phenylpropanamide)......................................................983323(60) Metonitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-24benzimidazol-1-yl)ethan-1-amine).........................................................975725(61) Morpheridine............................................................................963226(62) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine)...............966127(63) MT-45 (1-cychohexyl-4-(1,2-diphenylethyl)piperazine).........956028(64) Noracymethadol.......................................................................963329(65) Norlevorphanol........................................................................963430(66) Normethadone..........................................................................963531(67) Norpipanone.............................................................................963632(68) Ocfentanil (N-(2-fluorophenyl)-2-methoxy-N-(1-33phenethylpiperidin-4-yl) 34acetamide)..............................................................................................983835(69) O-desmethyltramadol (Some trade or other names: 2-36((dimethylamino)methyl-1-(3-hydroxyphenyl)cyclohexanol;3-(2-37((dimethylamino)methyl)-1-hydroxycyclohexyl)phenol)38(70) Ortho-fluoroacryl fentanyl (N-(2-fluorophenyl)-N-(1-39phenethylpiperidin-4-yl)acrylamide).....................................................985240(71) Ortho-fluorobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-41phenethylpiperidin-4-yl)butyramide; also known as 2-fluorobutyryl 42fentanyl).................................................................................................984643(72) Ortho-fluorofentanyl (N-(2-fluorophenyl)-N-(1-1phenethylpiperidin-4-yl)propionamide; 2-fluorofentanyl)....................98162(73) Ortho -Fluorofuranyl fentanyl ( N -(2-fluorophenyl)- N -(1-3phenethylpiperidin-4-yl)furan-2-carboxamide).....................................98634(74) (Ortho-fluoroisobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-5phenethylpiperidin-4-yl)isobutyramide)................................................98536(75) Ortho-methyl acetylfentanyl (N-(2-methylphenyl)-N-(1-7phenethylpiperidin-4-yl)acetamide; also known as 2-methyl 8acetylfentanyl)........................................................................................98489(76) Ortho-methyl methoxyacetyl fentanyl (2-methoxy-N-(2-10methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide; also known as 2-11methyl methoxyacetyl12 fentanyl)...................................................................................982013(77) Para-chloroisobutyryl fentanyl (N-(4-chlorophenyl)-N-(1-14phenethylpiperidin-4-yl)isobutyramide)................................................982615(78) Para-fluorobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-16phenethylpiperidin-4-yl)butyramide).....................................................982317(79) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-18piperidinyl]propanamide).......................................................................981219(80) Para-fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-20phenethylpiperidin-4-yl)isobutyramide, 4-fluoroisobutyryl fentanyl)21 ….............................................................................................982422(81) Para-fluoro furanyl fentanyl (N-(4-fluorophenyl)-N-(1-23phenethylpiperidin-4-yl)furan-2-carboxamide).....................................985424(82) Para-methoxybutyryl fentanyl (N-(4-methoxyphenyl)-N-(1-25phenethylpiperidin-4-yl)butyramide)....................................................983726(83) Para -Methoxyfuranyl fentanyl ( N -(4-methoxyphenyl)- N -(1-27phenethylpiperidin-4-yl)furan-2-carboxamide.......................................985928(84) para -Methylcyclopropyl fentanyl ( N -(4-methylphenyl)- N -(1-29phenethylpiperidin-4-yl)cyclopropanecarboxamide).............................986530(85) Para-methylfentanyl (N-(4-methylphenyl)-N-(1-31phenethylpiperidin-4-yl)propionamide; also known as 4-methylfentanyl)32 …..............................................................................................981733(86) PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine)34 …..............................................................................................966335(87) Phenadoxone............................................................................963736(88) Phenampromide.......................................................................963837(89) Phenomorphan.........................................................................964738(90) Phenoperidine...........................................................................964139(91) Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-40phenylbenzamide; also known as benzoyl fentanyl)..............................984141(92) Piritramide................................................................................964242(93) Proheptazine.............................................................................964343(94) Properidine...............................................................................96441(95) Propiram..................................................................................96492(96) Racemoramide.........................................................................96453(97) Tetrahydrofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-4phenyltetrahydrofuran-2-carboxamide).................................................98435(98) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-6propanamide).........................................................................................98357(99) Thiofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-8phenylthiophene-2-carboxamide; also known as 2-thiofuranyl fentanyl; 9thiophene fentanyl)................................................................................983910(100) Tilidine....................................................................................975011(101) Trimeperidine..........................................................................964612(102) U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-13 methylbenzamide)....................................................................954714(103) Valeryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-15phenylpentanamide)...............................................................................984016(104) Zipeprol (1-methoxy-3-[4-(2-methoxy-2-phenylethyl)piperazin-1-17yl]-1-phenylpropan-2-ol)........................................................................98731819(c) Any of the following opium derivatives, their salts, isomers and 20salts of isomers, unless specifically excepted, whenever the existence of 21these salts, isomers and salts of isomers is possible within the specific 22chemical designation:23(1) Acetorphine..............................................................................931924(2) Acetyldihydrocodeine..............................................................905125(3) Benzylmorphine.......................................................................905226(4) Codeine methylbromide...........................................................907027(5) Codeine-N-Oxide.....................................................................905328(6) Cyprenorphine..........................................................................905429(7) Desomorphine..........................................................................905530(8) Dihydromorphine.....................................................................914531(9) Drotebanol................................................................................933532(10) Etorphine (except hydrochloride salt)......................................905633(11) Heroin.......................................................................................920034(12) Hydromorphinol.......................................................................930135(13) Methyldesorphine.....................................................................930236(14) Methyldihydromorphine..........................................................930437(15) Morphine methylbromide........................................................930538(16) Morphine methylsulfonate.......................................................930639(17) Morphine-N-Oxide...................................................................930740(18) Myrophine................................................................................930841(19) Nicocodeine.............................................................................930942(20) Nicomorphine 43(21) Normorphine............................................................................93131(22) Pholcodine................................................................................93142(23) Thebacon..................................................................................931534(d) Any material, compound, mixture or preparation that contains any 5quantity of the following hallucinogenic substances, their salts, isomers 6and salts of isomers, unless specifically excepted, whenever the existence 7of these salts, isomers and salts of isomers is possible within the specific 8chemical designation:9(1) Alpha-ethyltryptamine.............................................................724910Some trade or other names: etryptamine; Monase; α-ethyl-1H-indole-3-11ethanamine; 3-(2-aminobutyl) indole; α-ET; and AET.12(2) 4-bromo-2,5-dimethoxy-amphetamine....................................739113Some trade or other names: 4-bromo-2,5-dimethoxy-alpha-14methylphenethylamine; 4-bromo-2,5-DMA.15(3) 2,5-dimethoxyamphetamine.....................................................739616Some trade or other names: 2,5-dimethoxy-alpha-methyl-phenethylamine; 172,5-DMA.18(4) 4-methoxyamphetamine...........................................................741119Some trade or other names: 4-methoxy-alpha-methylphene-thylamine; 20paramethoxyamphetamine; PMA.21(5) 5-methoxy-3,4-methylenedioxy-amphetamine........................740122(6) 4-methyl-2,5-dimethoxy-amphetamine....................................739523Some trade or other names: 4-methyl-2,5-dimethoxy-alpha-24methylphenethylamine; "DOM"; and "STP".25(7) 3,4-methylenedioxy amphetamine...........................................740026(8) 3,4-methylenedioxymethamphetamine (MDMA)...................740527(9) 3,4-methylenedioxy-N-ethylamphetamine (also known as N-28ethyl-alpha-methyl-3,4 (methylenedioxy) phenethylamine, N-ethyl MDA, 29MDE, and MDEA).................................................................................740430(10) N-hydroxy-3,4-methylenedioxyamphetamine (also known as N-31hydroxy-alpha-methyl-3,4-(methylenedioxy) phenethylamine, and N-32hydroxy MDA).......................................................................................740233(11) 3,4,5-trimethoxy amphetamine................................................739034(12) Bufotenine................................................................................743335Some trade or other names: 3-(Beta-Dimethylaminoethyl)-5-36hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; N, N-37dimethylserotonin; 5-hydroxy-N,N-dimethyltryptamine; mappine.38(13) Diethyltryptamine....................................................................743439Some trade or other names: N,N-Diethyltryptamine; DET.40(14) Dimethyltryptamine.................................................................743541Some trade or other names: DMT.42(15) Ibogaine …...............................................................................726043Some trade or other names: 7-Ethyl-6,6 Beta,7,8,9,10,12,13-octahydro-2-1methoxy-6,9-methano-5H-pyrido[1',2':1,2]azepino[5,4-b]indole; 2Tabernanthe iboga3(16) Lysergic acid diethylamide......................................................73154(17) Marijuana.................................................................................73605(18) Mescaline.................................................................................73816(19)(18) Parahexyl.................................................................................73747Some trade or other names: 3-Hexyl-l-hydroxy-7,8,9,10-tetrahydro-6,6,9-8trimethyl-6H-dibenzo[b,d]pyran; Synhexyl.9(20)(19) Peyote......................................................................................741510Meaning all parts of the plant presently classified botanically as 11Lophophora williamsii Lemaire, whether growing or not, the seeds 12thereof, any extract from any part of such plant, and every compound, 13manufacture, salts, derivative, mixture or preparation of such plant, its 14seeds or extracts.15(21)(20) N-ethyl-3-piperidyl benzilate...................................................748216(22)(21) N-methyl-3-piperidyl benzilate................................................748417(23)(22) Psilocybin.................................................................................743718(24)(23) Psilocyn …................................................................................743819Some trade or other names: Psilocin.20(25)(24) Ethylamine analog of phencyclidine........................................745521Some trade or other names: N-ethyl-1-phenyl-cyclo-hexylamine; (1-22phenylcyclohexyl)ethylamine; N-(1-phenylcyclohexyl)ethylamine; 23cyclohexamine; PCE.24(26)(25) Pyrrolidine analog of phencyclidine........................................745825Some trade or other names: 1-(1-phenylcyclohexyl)-pyrrolidine; PCPy; 26PHP.27(27)(26) Thiophene analog of phencyclidine 747028Some trade or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine; 2-29thienyl analog of phencyclidine; TPCP; TCP.30(28)(27) 1-[1-(2-thienyl)-cyclohexyl] pyrrolidine..................................747331Some other names: TCPy.32(29)(28) 2,5-dimethoxy-4-ethylamphetamine........................................739933Some trade or other names: DOET.34(30)(29) Salvia divinorum or salvinorum A; all parts of the plant presently 35classified botanically as salvia divinorum, whether growing or not, the 36seeds thereof, any extract from any part of such plant, and every 37compound, manufacture, salts, derivative, mixture or preparation of such 38plant, its seeds or extracts.39(31)(30) Datura stramonium, commonly known as gypsum weed or jimson 40weed; all parts of the plant presently classified botanically as datura 41stramonium, whether growing or not, the seeds thereof, any extract from 42any part of such plant, and every compound, manufacture, salts, derivative, 43mixture or preparation of such plant, its seeds or extracts.1(32)(31) 1-(3-[trifluoromethylphenyl])piperazine2Some trade or other names: TFMPP.3(33)(32) 4-Bromo-2,5-dimethoxyphenethylamine.................................73924(34)(33) 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7), its 5optical isomers, salts and salts of optical isomers..................................73486(35)(34) Alpha-methyltryptamine (other name: AMT)..........................74327(36)(35) 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT), its 8isomers, salts and salts of isomers..........................................................74399(37)(36) 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E).............750910(38)(37) 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D)11 …..............................................................................................750812(39)(38) 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C)13 …..............................................................................................751914(40)(39) 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I)................751815(41)(40) 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2)16 …..............................................................................................738517(42)(41) 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]18ethanamine (2C-T-4)..............................................................................753219(43)(42) 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H).........................751720(44)(43) 2-(2,5-Dimethoxy-4-nitrophenyl)ethanamine (2C-N).............752121(45)(44) 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P)22 …..............................................................................................752423(46)(45) 5–methoxy–N,N–dimethyltryptamine (5–MeO–DMT)24 …..............................................................................................743125Some trade or other names: 5–methoxy–3–[2–(dimethylamino) 26ethyl]indole.27(47)(46) 2–(4–iodo–2,5–dimethoxyphenyl)–N–(2–28methoxybenzyl)ethanamine 753829Some trade or other names: 25I–NBOMe; 2C–I–NBOMe; 25I; 30Cimbi–5.31(48)(47) 2–(4–chloro–2,5–dimethoxyphenyl)–N–(2–32methoxybenzyl)ethanamine 753733Some trade or other names: 25C–NBOMe; 2C–C–NBOMe; 25C; 34Cimbi–82.35(49)(48) 2–(4–bromo–2,5–dimethoxyphenyl)–N–(2–36methoxybenzyl)ethanamine 753637Some trade or other names: 25B–NBOMe; 2C–B–NBOMe; 25B; 38Cimbi–36.39(50)(49) 2-(2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine40Some trade or other names: 25H-NBOMe.41(51)(50) 2-(2,5-dimethoxy-4-methylphenyl)-N-(2-42methoxybenzyl)ethanamine43Some trade or other names: 25D-NBOMe; 2C-D-NBOMe.1(52)(51) 2-(2,5-dimethoxy-4-nitrophenyl)-N-(2-2methoxybenzyl)ethanamine3Some trade or other names: 25N-NBOMe, 2C-N-NBOMe.4(53)(52) 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1 H-pyrrolo[2,3-5b]pyridine-3-carboxamide (5F-CUMYL-P7AICA) 70856(54)(53) 2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one (other 7names: methoxetamine, MXE) 72868(55)(54) 1-(4-methoxyphenyl)-N-methylpropan-2-amine (other names: 9para-methoxymethamphetamine, PMMA) 12451011(e) Any material, compound, mixture or preparation that contains any 12quantity of the following substances having a depressant effect on the 13central nervous system, including its salts, isomers, and salts of isomers 14whenever the existence of such salts, isomers, and salts of isomers is 15possible within the specific chemical designation:16(1) Etizolam 278017Some trade or other names: (4-(2-chlorophenyl)-2-ethyl-9-methyl-186H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine)19(2) Mecloqualone 257220(3) Methaqualone 256521(4) Gamma hydroxybutyric acid 201022(5) 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-benzo[f]23[1,2,4]triazolo[4,3-a][1,4]diazepine, its salts, isomers, and salts of isomers24 (other name: flualprazolam) 278525(6) 6-(2-chlorophenyl)-1-methyl-8-nitro-4H-benzo[f][1,2,4]triazolo[4,3-26a][1,4]diazepine, its salts, isomers, and salts of isomers (other name: 27clonazolam) 278628(7) 8-bromo-6-(2-fluorophenyl)-1-methyl-4H-benzo[f]29[1,2,4]triazolo[4,3-a][1,4]diazepine, its salts, isomers, and salts of isomers30 (other name: flubromazolam) 278831(8) 7-chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-benzo[e]32[1,4]diazepin-2-one, its salts, isomers, and salts of isomers (other name: 33diclazepam) 27893435(f) Unless specifically excepted or unless listed in another schedule, 36any material, compound, mixture or preparation that contains any quantity 37of the following substances having a stimulant effect on the central 38nervous system, including its salts, isomers and salts of isomers:39(1) Aminorex 158540Some other names: Aminoxaphen 2-amino-5-phenyl-2-oxazoline or 414,5-dihydro-5-phenyl-2-oxazolamine42(2) Fenethylline 150343(3) N-ethylamphetamine 14751(4) (+)cis-4-methylaminorex ((+)cis-4,5-dihydro-4-methyl-5-phenyl-2-2oxazolamine) 15903(5) N,N-dimethylamphetamine (also known as N,N-alpha-trimethyl-4benzeneethanamine; N,N-alpha-trimethylphenethylamine) 14805(6) Cathinone (some other names: 2-amino-1-phenol-1-propanone, 6alpha-amino propiophenone, 2-amino propiophenone and 7norphedrone) 12358(7) Substituted cathinones9Any compound, except bupropion or compounds listed under a different 10schedule, structurally derived from 2–aminopropan–1–one by substitution 11at the 1-position with either phenyl, naphthyl, or thiophene ring systems, 12whether or not the compound is further modified in any of the following 13ways:14 (A) By substitution in the ring system to any extent with alkyl, 15alkylenedioxy, alkoxy, haloalkyl, hydroxyl, or halide substituents, whether 16or not further substituted in the ring system by one or more other univalent 17substituents;18 (B) by substitution at the 3-position with an acyclic alkyl 19substituent;20 (C) by substitution at the 2-amino nitrogen atom with alkyl, 21dialkyl, benzyl, or methoxybenzyl groups; or22 (D) by inclusion of the 2-amino nitrogen atom in a cyclic 23structure.24(8) N-benzylpiperazine (other names: BZP, 1-benzylpiprazine)25 749326(9) Methiopropamine27(N-methyl-1-(thiophen-2-yl)propan-2-amine).......................................147828(10) 4,4′-Dimethylaminorex (4,4′-DMAR; 4,5-dihydro-4-methyl-5-(4-29methylphenyl)-2-oxazolamine; 4-methyl-5-(4-methylphenyl)-4,5-30dihydro-1,3-oxazol-2-amine) 159531(11) Amineptine (7-[(10,11-dihydro-5 H-dibenzo[a,d]cyclohepten-5-32yl)amino]heptanoic acid) 121933(12) Mesocarb (N-phenyl-N ′-(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-343-ium-5-yl)carbamimidate) 12273536(g) Any material, compound, mixture or preparation that contains any 37quantity of the following substances:38(1) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl), 39its optical isomers, salts and salts of isomers40(2) N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide 41(thenylfentanyl), its optical isomers, salts and salts of isomers42(3) Tianeptine, its optical isomers, salts and salts of isomers431(h) Any of the following cannabinoids, their salts, isomers and salts 2of isomers, unless specifically excepted, whenever the existence of these 3salts, isomers and salts of isomers is possible within the specific chemical 4designation:5(1) Tetrahydrocannabinols 73706Meaning tetrahydrocannabinols naturally contained in a plant of the 7genus Cannabis (cannabis plant), as well as synthetic equivalents of 8the substances contained in the plant, or in the resinous extractives of 9Cannabis, sp. and/or synthetic substances, derivatives, and their 10isomers with similar chemical structure and pharmacological activity 11such as the following: Delta 1 cis or trans tetrahydrocannabinol, and 12their optical isomers Delta 6 cis or trans tetrahydrocannabinol, and 13their optical isomers Delta 3,4 cis or trans tetrahydrocannabinol, and 14its optical isomers (Since nomenclature of these substances is not 15internationally standardized, compounds of these structures, 16regardless of numerical designation of atomic positions covered.), 17except tetrahydrocannabinols in any of the following:18 (A) Industrial hemp, as defined in K.S.A. 2-3901, and 19amendments thereto;20 (B) solid waste, as defined in K.S.A. 65-3402, and amendments 21thereto, and hazardous waste, as defined in K.S.A. 65-3430, and 22amendments thereto, if such waste is the result of the cultivation, 23production or processing of industrial hemp, as defined in K.S.A. 2-3901, 24and amendments thereto, and such waste contains a delta-9 25tetrahydrocannabinol concentration of not more than 0.3%; or26 (C) hemp products, as defined in K.S.A. 2-3901, and amendments 27thereto, unless otherwise deemed unlawful pursuant to K.S.A. 2-3908, and 28amendments thereto.29(2) Naphthylmethylindoles30Any compound containing a 1H-indol-3-yl-(1-naphthyl)methane structure 31with substitution at the nitrogen atom of the indole group by an alkyl, 32haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, 331-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group 34whether or not further substituted on the indole group to any extent and 35whether or not substituted on the benzyl or naphthyl ring to any extent.36(3)(2) Naphthoylpyrroles37Any compound containing a 3-(1-naphthoyl)pyrrole structure with 38substitution at the nitrogen atom of the pyrrole group by an alkyl, 39haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, 401-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group 41whether or not further substituted on the pyrrole group to any extent, 42whether or not substituted on the benzyl or naphthyl ring to any extent.43(4)(3) Naphthylmethylindenes1Any compound containing a naphthylmethylindene structure with 2substitution at the 3-position of the indene group by an alkyl, haloalkyl, 3cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, 1-(N-4methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group whether or 5not further substituted on the indene group to any extent, whether or not 6substituted on the benzyl or naphthyl ring to any extent.7(5)(4) Cyclohexylphenols8Any compound containing a 2-(3-hydroxycyclohexyl)phenol structure 9with substitution at the 5-position of the phenolic ring by an alkyl, 10haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-11methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group whether or 12not substituted on the cyclohexyl ring to any extent.13(6)(5) 2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-141,4-benzoxazin-6-yl]-1-napthalenylmethanone.15Some trade or other names: WIN 55,212-2.16(7)(6) 9-(hydroxymethyl)-6, 6-dimethyl-3-(2-methyloctan-2-yl)-176a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol18Some trade or other names: HU-210, HU-211.19(8)(7) Indole-3-carboxylate esters20Any compound containing a 1H-indole-3-carboxylate ester structure with 21the ester oxygen bearing a naphthyl, quinolinyl, isoquinolinyl or 22adamantyl group and substitution at the 1 position of the indole ring by an 23alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 24benzyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl 25group, whether or not further substituted on the indole ring to any extent 26and whether or not substituted on the naphthyl, quinolinyl, isoquinolinyl, 27adamantyl or benzyl groups to any extent.28(9)(8) Indazole-3-carboxamides29Any compound containing a 1H-indazole-3-carboxamide structure with 30substitution at the nitrogen of the carboxamide by a naphthyl, quinolinyl, 31isoquinolinyl, adamantyl, benzyl, 1-amino-1-oxoalkan-2-yl or 1-alkoxy-1-32oxoalkan-2-yl group and substitution at the 1 position of the indazole ring 33by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, 34cycloalkylethyl, benzyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-35morpholinyl)ethyl group, whether or not further substituted on the 36indazole ring to any extent and whether or not substituted on the naphthyl, 37quinolinyl, isoquinolinyl, adamantyl, 1-amino-1-oxoalkan-2-yl, 1-alkoxy-381-oxoalkan-2-yl or benzyl groups to any extent.39(10)(9) Indole-3-carboxamides40Any compound containing a 1H-indole-3-carboxamide structure with 41substitution at the nitrogen of the carboxamide by a naphthyl, quinolinyl, 42isoquinolinyl, adamantyl, benzyl, 1-amino-1-oxoalkan-2-yl or 1-alkoxy-1-43oxoalkan-2-yl group and substitution at the 1 position of the indole ring by 1an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, 2cycloalkylethyl, benzyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-3morpholinyl)ethyl group, whether or not further substituted on the indole 4ring to any extent and whether or not further substituted on the naphthyl, 5quinolinyl, isoquinolinyl, adamantyl, 1-amino-1-oxoalkan-2-yl, 1-alkoxy-61-oxoalkan-2-yl or benzyl groups to any extent.7(11)(10) (1H-indazol-3-yl)methanones8Any compound containing a (1H-indazol-3-yl)methanone structure with 9the carbonyl carbon bearing a naphthyl group and substitution at the 1 10position of the indazole ring by an alkyl, haloalkyl, alkenyl, 11cycloalkylmethyl, cycloalkylethyl, benzyl, 1-(N-methyl-2-12piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not 13further substituted on the indazole ring to any extent and whether or not 14substituted on the naphthyl or benzyl groups to any extent.15(12)(11) (1H-indol-3-yl)methanones16Any compound containing a (1H-indol-3-yl)methanone structure with the 17carbonyl carbon bearing a naphthyl, quinolinyl, isoquinolinyl, adamantyl, 18phenyl, benzyl or tetramethylcyclopropyl group and substitution at the 1 19position of the indole ring by an alkyl,haloalkyl, cyanoalkyl, alkenyl, 20cycloalkylmethyl, cycloalkylethyl, benzyl, 1-(N-methyl-2-21piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-22pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or 23tetrahydropyranylmethyl group, whether or not further substituted on the 24indole ring to any extent and whether or not substituted on the naphthyl, 25quinolinyl, isoquinolinyl, adamantyl, phenyl, benzyl or 26tetramethylcyclopropyl groups to any extent.2728Sec. 3. K.S.A. 65-4109 is hereby amended to read as follows: 65-294109. (a) The controlled substances listed in this section are included in 30schedule III and the number set forth opposite each drug or substance is 31the DEA controlled substances code which has been assigned to it.32(b) Unless listed in another schedule, any material, compound, 33mixture, or preparation which contains any quantity of the following 34substances having a potential for abuse associated with a depressant effect 35on the central nervous system:36(1) Any compound, mixture or preparation containing:37(A) Amobarbital 212638(B) Secobarbital 231639(C) Pentobarbital 227140or any salt thereof and one or more other active medicinal 41ingredients which are not listed in any schedule.42(2) Any suppository dosage form containing:43(A) Amobarbital 21261(B) Secobarbital 23162(C) Pentobarbital 22713or any salt of any of these drugs and approved by the Food and 4Drug Administration for marketing only as a suppository.5(3) Any substance which contains any quantity of a derivative of 6barbituric acid, or any salt of a derivative of barbituric acid, except 7those substances which are specifically listed in other schedules 21008(4) Chlorhexadol 25109(5) Lysergic acid 730010(6) Lysergic acid amide 731011(7) Methyprylon 257512(8) Sulfondiethylmethane 260013(9) Sulfonethylmethane 260514(10) Sulfonmethane 261015(11) Tiletamine and zolazepam or any salt thereof 729516Some trade or other names for a tiletamine-zolazepam combination 17product: Telazol18Some trade or other names for tiletamine: 2-(ethylamino)-2-(2-19thienyl)-cyclohexanone20Some trade or other names for zolazepam: 4-(2-fluorophenyl)-6,8-21dihydro-1,3,8-trimethylpyrazolo-[3,4-e][1,4]-diazepin-7(1H)-one, 22flupyrazapon23(12) Ketamine, its salts, isomers, and salts of isomers 728524Some other names for ketamine: (±)-2-(2-chlorophenyl)-2-25(methylamino)-cyclohexanone26(13) Gamma hydroxybutyric acid, any salt, hydroxybutyric compound, 27derivative or preparation of gamma hydroxybutyric acid contained in 28a drug product for which an application has been approved under 29section 505 of the federal food, drug and cosmetic act30(14) Embutramide 202031(15) Perampanel, its salts, isomers, and salts of isomers 226132Some other names for perampanel: 2-(2-oxo-1-phenyl-5-pyridin-2-33yl-1,2 dihydropyridin-3-yl) benzonitrile3435(c) Nalorphine 940036(d) Any material, compound, mixture or preparation containing any 37of the following narcotic drugs or any salts calculated as the free 38anhydrous base or alkaloid, in limited quantities as set forth below:39(1) Not more than 1.8 grams of codeine or any of its salts per 100 40milliliters or not more than 90 milligrams per dosage unit with an 41equal or greater quantity of an isoquinoline alkaloid of opium 980342(2) not more than 1.8 grams of codeine or any of its salts per 100 43milliliters or not more than 90 milligrams per dosage unit with one or 1more active, nonnarcotic ingredients in recognized therapeutic 2amounts 98043(3) not more than 1.8 grams of dihydrocodeine or any of its salts per 100 4milliliters or not more than 90 milligrams per dosage unit with one or 5more active, nonnarcotic ingredients in recognized therapeutic 6amounts 98077(4) not more than 300 milligrams of ethylmorphine or any of its salts per 8100 milliliters or not more than 15 milligrams per dosage unit with 9one or more active, nonnarcotic ingredients in recognized therapeutic 10amounts 980811(5) not more than 500 milligrams of opium per 100 milliliters or per 100 12grams or not more than 25 milligrams per dosage unit with one or 13more active, nonnarcotic ingredients in recognized therapeutic 14amounts 980915(6) not more than 50 milligrams of morphine or any of its salts per 100 16milliliters or per 100 grams with one or more active, nonnarcotic 17ingredients in recognized therapeutic amounts 981018(7) any material, compound, mixture or preparation containing any of the 19following narcotic drugs or their salts, as set forth below:20(A) Buprenorphine 90642122(e) Unless specifically excepted or unless listed in another schedule, 23any material, compound, mixture or preparation which contains any 24quantity of the following substances having a stimulant effect on the 25central nervous system, including its salts, isomers (whether optical, 26position or geometric) and salts of such isomers whenever the existence of 27such salts, isomers and salts of isomers is possible within the specific 28chemical designation:29(1) Those compounds, mixtures or preparations in dosage unit form 30containing any stimulant substance listed in schedule II, which 31compounds, mixtures or preparations were listed on August 25, 1971, 32as excepted compounds under section 308.32 of title 21 of the code 33of federal regulations, and any other drug of the quantitive 34composition shown in that list for those drugs or which is the same, 35except that it contains a lesser quantity of controlled substances 140536(2) Benzphetamine 122837(3) Chlorphentermine 164538(4) Chlortermine 164739(5) Phendimetrazine 16154041(f) Anabolic steroids 400042"Anabolic steroid" means any drug or hormonal substance, chemically 43and pharmacologically related to testosterone (other than estrogens, 1progestins, and corticosteroids) that promotes muscle growth, and 2includes:3(1) 3β,17-dihydroxy-5a-androstane4(2) 3α,17β-dihydroxy-5a-androstane5(3) 5α-androstan-3,17-dione6(4) 1-androstenediol (3β,17β-dihydroxy-5α-androst-1-ene)7(5) 1-androstenediol (3α,17β-dihydroxy-5α-androst-1-ene)8(6) 4-androstenediol (3β,17β-dihydroxy-androst-4-ene)9(7) 5-androstenediol (3β,17β-dihydroxy-androst-5-ene)10(8) 1-androstenedione ([5α]-androst-1-en-3,17-dione)11(9) 4-androstenedione (androst-4-en-3,17-dione)12(10) 5-androstenedione (androst-5-en-3,17-dione)13(11) bolasterone (7α,17α-dimethyl-17β-hydroxyandrost-4-en-3-one)14(12) boldenone (17β-hydroxyandrost-1,4-diene-3-one)15(13) boldione (androsta-1,4-diene-3,17-dione)16(14) calusterone (7β,17α-dimethyl-17β-hydroxyandrost-4-en-3-one)17(15) clostebol (4-chloro-17β-hydroxyandrost-4-en-3-one)18(16) dehydrochloromethyltestosterone (4-chloro-17β-hydroxy-17α-19methyl-androst-1,4-dien-3-one)20(17) desoxymethyltestosterone (17α-methyl-5α-androst-2-en-17β-ol) (also 21known as "madol")22(18) Δ1-dihydrotestosterone (17β-hydroxy-5α-androst-1-en-3-one) (also 23known as "1-testosterone")24(19) 4-dihydrotestosterone (17β-hydroxy-androstan-3-one)25(20) drostanolone (17β-hydroxy-2α-methyl-5α-androstan-3-one)26(21) ethylestrenol (17α-ethyl-17β-hydroxyestr-4-ene)27(22) fluoxymesterone (9-fluoro-17α-methyl-11β,17β-dihydroxyandrost-4-28en-3-one)29(23) formebolone (2-formyl-17α-methyl-11α,17β-dihydroxyandrost-1,4-30dien-3-one)31(24) furazabol (17α-methyl-17β-hydroxyandrostano[2,3-c]-furazan)32(25) 13β-ethyl-17β-hydroxygon-4-en-3-one33(26) 4-hydroxytestosterone (4,17β-dihydroxy-androst-4-en-3-one)34(27) 4-hydroxy-19-nortestosterone (4,17β-dihydroxy-estr-4-en-3-one)35(28) mestanolone (17α-methyl-17β-hydroxy-5-androstan-3-one)36(29) mesterolone (1α-methyl-17β-hydroxy-[5α]-androstan-3-one)37(30) methandienone (17α-methyl-17β-hydroxyandrost-1,4-dien-3-one)38(31) methandriol (17α-methyl-3β,17β-dihydroxyandrost-5-ene)39(32) methasterone (2α,17α-dimethyl-5α-androstan-17β-ol-3-one)40(33) methenolone (1-methyl-17β-hydroxy-5α-androst-1-en-3-one)41(34) 17α-methyl-3β,17β-dihydroxy-5a-androstane42(35) 17α-methyl-3α,17β-dihydroxy-5a-androstane43(36) 17α-methyl-3β,17β-dihydroxyandrost-4-ene1(37) 17α-methyl-4-hydroxynandrolone (17α-methyl-4-hydroxy-17β-2hydroxyestr-4-en-3-one)3(38) methyldienolone (17α-methyl-17β-hydroxyestra-4,9(10)-dien-3-one)4(39) methyltrienolone (17α-methyl-17β-hydroxyestra-4,9,11-trien-3-one)5(40) methyltestosterone (17α-methyl-17β-hydroxyandrost-4-en-3-one)6(41) mibolerone (7α,17α-dimethyl-17β-hydroxyestr-4-en-3-one)7(42) 17α-methyl-Δ1-dihydrotestosterone (17β-hydroxy-17α-methyl-5α-8androst-1-en-3-one) (also known as "17-α-methyl-1-testosterone")9(43) nandrolone (17β-hydroxyestr-4-en-3-one)10(44) 19-nor-4-androstenediol (3β, 17β-dihydroxyestr-4-ene)11(45) 19-nor-4-androstenediol (3α, 17β-dihydroxyestr-4-ene)12(46) 19-nor-5-androstenediol (3β, 17β-dihydroxyestr-5-ene)13(47) 19-nor-5-androstenediol (3α, 17β-dihydroxyestr-5-ene)14(48) 19-nor-4,9(10)-androstadienedione (estra-4,9(10)-diene-3,17-dione)15(49) 19-nor-4-androstenedione (estr-4-en-3,17-dione)16(50) 19-nor-5-androstenedione (estr-5-en-3,17-dione)17(51) norbolethone (13β, 17α-diethyl-17β-hydroxygon-4-en-3-one)18(52) norclostebol (4-chloro-17β-hydroxyestr-4-en-3-one)19(53) norethandrolone (17α-ethyl-17β-hydroxyestr-4-en-3-one)20(54) normethandrolone (17α-methyl-17β-hydroxyestr-4-en-3-one)21(55) oxandrolone (17α-methyl-17β-hydroxy-2-oxa-[5α]-androstan-3-one)22(56) oxymesterone (17α-methyl-4,17β-dihydroxyandrost-4-en-3-one)23(57) oxymetholone (17α-methyl-2-hydroxymethylene-17β-hydroxy-[5α]-24androstan-3-one)25(58) prostanozol (17β-hydroxy-5α-androstano[3,2-c]pyrazole)26(59) stanozolol (17α-methyl-17β-hydroxy-[5α]-androst-2-eno[3,2-c]-27pyrazole)28(60) stenbolone (17β-hydroxy-2-methyl-[5α]-androst-1-en-3-one)29(61) testolactone (13-hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic 30acid lactone)31(62) testosterone (17β-hydroxyandrost-4-en-3-one)32(63) tetrahydrogestrinone (13β, 17α-diethyl-17β-hydroxygon-4,9,11-trien-333-one)34(64) trenbolone (17β-hydroxyestr-4,9,11-trien-3-one)35(65) any salt, ester, or isomer of a drug or substance described or listed in 36this paragraph, if that salt, ester, or isomer promotes muscle growth.37(A) Except as provided in (B), such term does not include an 38anabolic steroid which that is expressly intended for 39administration through implants to cattle or other nonhuman 40species and which that has been approved by the United States' 41secretary of health and human services for such administration.42(B) If any person prescribes, dispenses or distributes such steroid 43for human use, such person shall be considered to have 1prescribed, dispensed or distributed an anabolic steroid within 2the meaning of this subsection (f).3(g) Any material, compound, mixture or preparation which contains 4any quantity of the following hallucinogenic substance, its salts, isomers 5and salts of isomers, unless specifically excepted, whenever the existence 6of these salts, isomers and salts of isomers is possible within the specific 7chemical designation:8(1) Dronabinol (synthetic) in sesame oil and encapsulated in a soft 9gelatin capsule in a United States food and drug administration 10approved product 736911Some other names for dronabinol: (6aR-trans)-6a,7,8,10a-tetrahydro-126-6-9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-0l, or (-)-delta-9-13(trans)-tetrahydrocannabinol.1415(h) Marijuana 736016(i) Tetrahydrocannabinols 737017Meaning tetrahydrocannabinols naturally contained in a plant of the 18genus Cannabis (cannabis plant), as well as synthetic equivalents of the 19substances contained in the plant, or in the resinous extractives of 20Cannabis, sp. and/or synthetic substances, derivatives, and their isomers 21with similar chemical structure and pharmacological activity such as the 22following: Delta 1 cis or trans tetrahydrocannabinol, and their optical 23isomers Delta 6 cis or trans tetrahydrocannabinol, and their optical 24isomers Delta 3,4 cis or trans tetrahydrocannabinol, and its optical 25isomers (Since nomenclature of these substances is not internationally 26standardized, compounds of these structures, regardless of numerical 27designation of atomic positions covered.), except tetrahydrocannabinols in 28any of the following:29(1) Industrial hemp, as defined in K.S.A. 2-3901, and amendments 30thereto;31(2) solid waste, as defined in K.S.A. 65-3402, and amendments 32thereto, and hazardous waste, as defined in K.S.A. 65-3430, and 33amendments thereto, if such waste is the result of the cultivation, 34production or processing of industrial hemp, as defined in K.S.A. 2-3901, 35and amendments thereto, and such waste contains a delta-9 36tetrahydrocannabinol concentration of not more than 0.3%; or37(3) hemp products, as defined in K.S.A. 2-3901, and amendments 38thereto, unless otherwise deemed unlawful pursuant to K.S.A. 2-3908, and 39amendments thereto.40(j) The board may except by rule any compound, mixture or 41preparation containing any stimulant or depressant substance listed in 42subsection (b) from the application of all or any part of this act if the 43compound, mixture or preparation contains one or more active medicinal 1ingredients not having a stimulant or depressant effect on the central 2nervous system and if the admixtures are included therein in combinations, 3quantity, proportion or concentration that vitiate the potential for abuse of 4the substances which have a stimulant or depressant effect on the central 5nervous system.6Sec. 4. K.S.A. 21-5706 and 65-4109 and K.S.A. 2025 Supp. 65-4105 7are hereby repealed.8Sec. 5. This act shall take effect and be in force from and after its 9publication in the statute book. search keyboard_arrow_up keyboard_arrow_down Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Page 13 Page 14 Page 15 Page 16 Page 17 Page 18 Page 19 Page 20 Page 21 arrow_upward Top Kansas State Legislature

    300 SW 10th Ave, Topeka, KS 66612

    Ad Astra Per Aspera

    Kansas Legislative Hotline
    In-State: 1-800-432-3924
    Out-of-State: 785-296-2149

    Government

    • Legislators
    • House
    • Representatives
    • Senate
    • Senators
    • Committees

    Resources

    • Bills & Measures
    • Today
    • Live
    • Journals
    • Calendars
    • Archived Records
    • Laws
    • Search
    • RSS Feeds

    Support

    • Contact Us
    • Accessibility
    • Privacy Policy
    • Visit Us
    © 2026 Kansas State Legislature. All rights reserved. Data updated 0 minutes ago · 3:57 PM 11/14/2026

    Official text from the Kansas Legislature. Formatting has been adapted for reading on Ratifi.